NCT06103747View on ClinicalTrials.gov

Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

August 5, 2023

Study Completion Date

August 15, 2023

Conditions
Fed Conditions
Interventions
DRUG

Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)

Pharmacokinetic comparison after administration of test drug

DRUG

Galvumet® Film Coated Tablets (850 mg / 50 mg)

Pharmacokinetic comparison after administration of reference drug

Trial Locations (1)

1006

Centre National Chalbi Belkahia de Pharmacovogilance, Bab Souika

All Listed Sponsors
collaborator

Société Arabe des Industries Pharmaceutiques SAIPH - Tunisia

UNKNOWN

collaborator

Centre National Chalbi Belkahia de Pharmacovigilance CNPV - Tunisia

UNKNOWN

lead

Reseach Laboratory of Clinical and Experimental Pharmacology

NETWORK